Rolland, Y. et al. 2008. Frailty, osteoporosis and hip fracture: causes, consequences and therapeutic perspectives. Journal of Nutrition, Health and Aging 12(5):335-46.
Rosario, E.R., Chang, L., Head, E.H., Stanczyk, F.Z., Pike, C.J. 2009. Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer’s disease. Neurobiology of Aging May 8. [Epub ahead of print],
Rudman, D., Feller, A.G., Nagraj, H.S., Gergans, G.A., Lalitha, P.Y., Goldberg, A.F., Schlenker, R.A., Cohn, L., Rudman, I.W., Mattson, D.E. 1990. Effects of human growth hormone in men over 60 years old. New England Journal of Medicine 323(l):l-6.
Rasmussen, M.H., Wildschiodtz, G., Juul, A., Hilsted, J. 2008. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss. Obesity 16:1516–1521.
Schaffer, A., et al. 2007. Insulin-like growth factor-I and risk of high-grade cervical intraepithelial neoplasia. Cancer Epidemiology Biomarkers 8c Prevention 16(4):716-22.
Tenover, J.S. 2003. Declining testicular function in aging men. International Journal of Impotence Research 15(Suppl 4):S3-S8.
Villareal, D.T., Holloszy, J.O. 2004. Effect of DHEA on abdominal fat and insulin action in elderly women and men. JAMA 292(18):2243–2248.
Akehi, Y., Yoshimatsu, H. Kurokawa, M. Sakata, T. Eto, H. Ito, S., Ono, J. 2001. VLCD-induced weight loss improves heart rate variability in moderately obese Japanese. Experimental Biology and Medicine 226:440– 445.
American Academy of Sleep Medicine. Sleep restriction reduces heart rate variability. Physorg.com. June 13, 2007.
Buby, C., Elfner, L.F., May, J.G. Jr. 1990. Relaxation pretraining, pulse wave velocity and thermal biofeedback in the treatment of essential hypertension. International Journal of Psychophysiology 9(3):225-30.
Carney, R.M., et al. 2005. Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Archives of Internal Medicine 165(13):1486-91.
Duan, X., Tashiro, M. Wu, D., Yambe, T., Wang, Q. Sasaki, T., Kumagai, K. Luo, Y., Nitta, S., Itoh, M. 2007. Autonomic nervous function and localization of cerebral activity during lavender immersion. Technology and Health Care 15(2):69–78.
Grossman, P. 1992. Respiratory and cardiac rhythms as windows to central and autonomic biobehavioral regulation: Selection of window frames, keeping the panes clean and viewing neural topography. Biological Psychology 34:131–161.
Hahn, Y.B., Ro, Y.J., Song, H.H., Kim, N.C., Kim, H.S., Yoo, Y.S. 1993. The effect of thermal biofeedback and progressive muscle relaxation training in reducing blood pressure of patients with essential hypertension. Image — The Journal of Nursing Scholarship 25(3):204-7.
Haines, A.P., Imeson, J.D., Meade, T.W. 1987. Phobic anxiety and ischaemic heart disease. British Medical Journal 295:297–299.
Kawachi, I., Colditz, G.A., Ascherio, A., Rimm, E.B., Giovannucci, E., Stampfer, M.J., Willett, W.C. 1994. Prospective study of phobic anxiety and risk of coronary heart disease. Circulation 89:1992–1997.
Kawachi, I., Sparrow, D., Vokonas, P.S., Weiss, S.T. 1994. Symptoms of anxiety and risk of coronary heart disease: The Normative Aging Study. Circulation 90:2225–2229.
Kawachi, I., Sparrow, D. Vokonas, P.S., Weiss, S.T. 1995. Decreased heart rate variability in men with phobic anxiety. American Journal of Cardiology 75:882–885.
Kristal-Boneh, E. Raifel, M. Froom, P., Ribak, J. 1995. Heart rate variability in health and disease. Scandinavian Journal of Work, Environment & Health 21:85–95.
Lavi, T., Karasik, A., Koren-Morag, N., Kanety, H. Feinberg, M., Shecther, M. 2009. The acute effect of various glycemic index dietary carbohydrates on endothelial function in nondiabetic overweight and obese subjects. Journal of the American College of Cardiology 53:2283-2287
McCraty, R., Atkinson, M., Tiller, W., Rein, G. Watkins, A.D. 1995. The effects of emotions on short-term power spectrum analysis of heart rate variability. American Journal of Cardiology 76(14): 1089–1093.
Mendoza, I., et al. Sudden death: the anniversary effect. American College of Cardiology Meeting 2008; Abstract 1029-100.
Miller, M. Mangano, C., Park, Y., Goel, R., Plotnick, G.D., Vogel, R.A. 2006. Impact of cinematic viewing on endothelial function. Heart 92(2):261-2.
Mittleman, M.A., Maclure, M. Sherwood, J.B., Mulry, R.P., Tofler, G.H., Jacobs, S.C., Friedman, R., Benson, H. Muller, J.E. 1995. Triggering of acute myocardial infarction onset by episodes of anger. Circulation 92:1720– 1725.
Neki, N.S., Singh, R.B., Rastogi, S.S. 2004. How brain influences neuro- cardiovascular dysfunction. Journal of Assocication of Physicians of India. 52:223-30.
Novoa, R., Hammonds, T., 2008. Clinical hypnosis for reduction of atrial fibrillation after coronary artery bypass graft surgery. Cleveland Clinic Journal of Medicine 75(Suppl 2):S44-7.
Offerhaus, R.E. 1980. Heart rate variability in psychiatry. In: RJ Kitney, Rompelman O (eds). The Study of Heart Rate Variability. Oxford: Oxford University Press, 225–238.
Sloan, R.P., Shapiro, P.A., Bigger, T. Jr., Bagiella, E., Steinman, R.C., Gorman, J.M. 1994. Cardiac autonomic control and hostility in healthy subjects. American Journal of Cardiology 74:298–300.
Souza, G.G., Mendoni;a-de-Souza A.C., Barros, E.M., Coutinho, E.F., Oliveira, L., Mendlowicz, M.V., Figueira, I., Volchan, E. 2007. Resilience and vagal tone predict cardiac recovery from acute social stress. Stress 10(4):368- 74.
Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. 1996. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93:1043-65.
Wain, H.J., Amen, D.G., Oetgen, W.J. 1983. Cardiac arrhythmias and hypnotic intervention: advantages, disadvantages, precautions, and theoretical considerations. American Journal of Clinical Hypnosis 26(1):1–4.
Yeragani, V.K., Balon, R., Pohl, R. Ramesh, C., Glitz, D., Weinberg, P., Merlos, B. 1990.
2006 National Survey on Drug Use and Health, Office of Applied Studies. NSDUH Series H-32, DHHS Publication No. SMA 07-4293.
Dopheide, J.A., Pliszka, S.R. 2009. Attention-deficit-hyperactivity disorder: an update. Pharmacotherapy. 29 (6):656-79.
Hambidge, K.M. Mild zinc deficiency in human subjects. In: Mills, C.F., ed. Zinc in Human Biology. New York: Springer-Verlag. 1989:281-96.
Heo et al. 2008. An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer’s disease. European Journal of Neurology 8:865-8.
Jang et al. 2008. Red ginseng for treating erectile dysfunction: a systematic review. British Journal of Clinical Pharmacology 4:444-50.
King, J.C., Cousins, R.J. Zinc. In: Shils, M.E., Shike, M. Ross, A.C., Caballero, B., Cousins, R.J., eds. Modern Nutrition in Health and Disease, 10th ed. Baltimore: Lippincott Williams & Wilkins, 2005:271-85.
Lee et al. 2008. Interactioin between warfarin and Panax ginseng in ischemic stroke patients. Journal of Alternative and Complementary Medicine 6:715-21.
Lee et al. 2008. Panax ginseng enhances cognitive performance in Alzheimer’s disease. Alzheimer Disease & Associated Disorders 3:222-6.
Liang et al. 2005. Panax notoginseng supplementation enhances physical performance during endurance exercise. Journal of Strength & Conditioning Research 1:108-14.
Reay et al. 2005. Single doses of Panax ginseng (GU5) reduce blood glucose levels and improve cognitive performance during sustained mental activity. Journal of Psychopharmacology 4:357-65.
Sotaniemi et al. 1995. Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care 10:1373- 5.
